208 related articles for article (PubMed ID: 19959225)
1. Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel.
Alani AW; Bae Y; Rao DA; Kwon GS
Biomaterials; 2010 Mar; 31(7):1765-72. PubMed ID: 19959225
[TBL] [Abstract][Full Text] [Related]
2. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
Zhao H; Li Q; Hong Z
Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
5. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
6. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
8. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
[TBL] [Abstract][Full Text] [Related]
9. Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(γ-propargyl L-glutamate): the substituent effect.
Zhao X; Poon Z; Engler AC; Bonner DK; Hammond PT
Biomacromolecules; 2012 May; 13(5):1315-22. PubMed ID: 22376183
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.
Wu H; Zhu L; Torchilin VP
Biomaterials; 2013 Jan; 34(4):1213-22. PubMed ID: 23102622
[TBL] [Abstract][Full Text] [Related]
11. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
12. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
Jiang Y; Zhou Y; Zhang CY; Fang T
Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
[TBL] [Abstract][Full Text] [Related]
14. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.
Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X
J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492
[TBL] [Abstract][Full Text] [Related]
15. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
16. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
Zhang L; He Y; Ma G; Song C; Sun H
Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
[TBL] [Abstract][Full Text] [Related]
18. A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.
Xie Z; Guan H; Chen X; Lu C; Chen L; Hu X; Shi Q; Jing X
J Control Release; 2007 Feb; 117(2):210-6. PubMed ID: 17188776
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.
Zou J; Zhang F; Zhang S; Pollack SF; Elsabahy M; Fan J; Wooley KL
Adv Healthc Mater; 2014 Mar; 3(3):441-8. PubMed ID: 23997013
[TBL] [Abstract][Full Text] [Related]
20. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
